Italia markets closed

BMY Oct 2024 44.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,0300+0,6700 (+49,26%)
In data: 10:35AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,3600
Aperto2,1400
Denaro1,9000
Domanda2,0800
Prezzo d'esercizio44,00
Scadenza2024-10-18
Min-Max giorno2,0300 - 2,1400
Contratto - Min-MaxN/D
Volume3
Open Interest857
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri